Placenta crucially affects formation of fetal congenital heart disease

It has been increasingly recognized that structural abnormalities and functional changes in the placenta can adversely affect developing fetal heart. In this article, we examine a role of the placenta as well as potential impact of placental insufficiency on a fetus with congenital heart disease (CH...

Full description

Saved in:
Bibliographic Details
Main Authors: V. I. Tsibizova, T. M. Pervunina, V. A. Artemenko, V. O. Bitsadze, K. E. Gotsiridze, I. I. Averkin, D. V. Blinov, N. Yu. Novikova
Format: Article
Language:Russian
Published: IRBIS LLC 2022-03-01
Series:Акушерство, гинекология и репродукция
Subjects:
Online Access:https://www.gynecology.su/jour/article/view/1242
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849697296659251200
author V. I. Tsibizova
T. M. Pervunina
V. A. Artemenko
V. O. Bitsadze
K. E. Gotsiridze
I. I. Averkin
D. V. Blinov
N. Yu. Novikova
author_facet V. I. Tsibizova
T. M. Pervunina
V. A. Artemenko
V. O. Bitsadze
K. E. Gotsiridze
I. I. Averkin
D. V. Blinov
N. Yu. Novikova
author_sort V. I. Tsibizova
collection DOAJ
description It has been increasingly recognized that structural abnormalities and functional changes in the placenta can adversely affect developing fetal heart. In this article, we examine a role of the placenta as well as potential impact of placental insufficiency on a fetus with congenital heart disease (CHD). The fetal heart and placenta are directly connected because they develop simultaneously with common regulatory and signaling pathways. Moreover, placenta-associated complications are more common in pregnant women carrying fetus with CHD, and the fetal response to placental insufficiency may lead to postnatal preservation of remodeled heart. The mechanisms underlying this placenta–fetus axis potentially consists of genetic factors, oxidative stress, chronic hypoxia, and/or angiogenic imbalance. Thus, the mother–placenta–fetus circulation is critical in understanding the CHD formation. It is necessary to study the changing factors involved in these processes for early identification, imaging, quantification of placental insufficiency, and development of new prenatal therapies in the CHD patient population.
format Article
id doaj-art-850d50f5da0449b083b133473f0e8e3c
institution DOAJ
issn 2313-7347
2500-3194
language Russian
publishDate 2022-03-01
publisher IRBIS LLC
record_format Article
series Акушерство, гинекология и репродукция
spelling doaj-art-850d50f5da0449b083b133473f0e8e3c2025-08-20T03:19:14ZrusIRBIS LLCАкушерство, гинекология и репродукция2313-73472500-31942022-03-01161667210.17749/2313-7347/ob.gyn.rep.2022.262708Placenta crucially affects formation of fetal congenital heart diseaseV. I. Tsibizova0T. M. Pervunina1V. A. Artemenko2V. O. Bitsadze3K. E. Gotsiridze4I. I. Averkin5D. V. Blinov6N. Yu. Novikova7Almazov National Medical Research Centre, Health Ministry of Russian FederationAlmazov National Medical Research Centre, Health Ministry of Russian FederationAlmazov National Medical Research Centre, Health Ministry of Russian FederationSechenov UniversityChachava ClinicAlmazov National Medical Research Centre, Health Ministry of Russian FederationInstitute for Preventive and Social Medicine; Lapino Clinical Hospital, GC «Mother and Child»Mechnikov North-Western State Medical University, Health Ministry of Russian FederationIt has been increasingly recognized that structural abnormalities and functional changes in the placenta can adversely affect developing fetal heart. In this article, we examine a role of the placenta as well as potential impact of placental insufficiency on a fetus with congenital heart disease (CHD). The fetal heart and placenta are directly connected because they develop simultaneously with common regulatory and signaling pathways. Moreover, placenta-associated complications are more common in pregnant women carrying fetus with CHD, and the fetal response to placental insufficiency may lead to postnatal preservation of remodeled heart. The mechanisms underlying this placenta–fetus axis potentially consists of genetic factors, oxidative stress, chronic hypoxia, and/or angiogenic imbalance. Thus, the mother–placenta–fetus circulation is critical in understanding the CHD formation. It is necessary to study the changing factors involved in these processes for early identification, imaging, quantification of placental insufficiency, and development of new prenatal therapies in the CHD patient population.https://www.gynecology.su/jour/article/view/1242congenital heart diseaseschdvascular endothelial growth factorvegfsoluble fms-like tyrosine kinase-1sflt-1placental growth factorplgf
spellingShingle V. I. Tsibizova
T. M. Pervunina
V. A. Artemenko
V. O. Bitsadze
K. E. Gotsiridze
I. I. Averkin
D. V. Blinov
N. Yu. Novikova
Placenta crucially affects formation of fetal congenital heart disease
Акушерство, гинекология и репродукция
congenital heart diseases
chd
vascular endothelial growth factor
vegf
soluble fms-like tyrosine kinase-1
sflt-1
placental growth factor
plgf
title Placenta crucially affects formation of fetal congenital heart disease
title_full Placenta crucially affects formation of fetal congenital heart disease
title_fullStr Placenta crucially affects formation of fetal congenital heart disease
title_full_unstemmed Placenta crucially affects formation of fetal congenital heart disease
title_short Placenta crucially affects formation of fetal congenital heart disease
title_sort placenta crucially affects formation of fetal congenital heart disease
topic congenital heart diseases
chd
vascular endothelial growth factor
vegf
soluble fms-like tyrosine kinase-1
sflt-1
placental growth factor
plgf
url https://www.gynecology.su/jour/article/view/1242
work_keys_str_mv AT vitsibizova placentacruciallyaffectsformationoffetalcongenitalheartdisease
AT tmpervunina placentacruciallyaffectsformationoffetalcongenitalheartdisease
AT vaartemenko placentacruciallyaffectsformationoffetalcongenitalheartdisease
AT vobitsadze placentacruciallyaffectsformationoffetalcongenitalheartdisease
AT kegotsiridze placentacruciallyaffectsformationoffetalcongenitalheartdisease
AT iiaverkin placentacruciallyaffectsformationoffetalcongenitalheartdisease
AT dvblinov placentacruciallyaffectsformationoffetalcongenitalheartdisease
AT nyunovikova placentacruciallyaffectsformationoffetalcongenitalheartdisease